Home » Topics » Regulatory

Regulatory
RSS

E.U. approval obtained for once-weekly Actonel/Optinate for postmenopausal osteoporosis

Jan. 2, 2003

Once-daily Depakote ER approved for certain forms of epilepsy

Jan. 2, 2003

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

Shire seeks approval of Adderall XR in adults

Dec. 23, 2002

Kytril available in oral solution for CINV and RINV

Dec. 23, 2002

Moxifloxacin NDA filed for bacterial conjunctivitis and ophthalmia neonatorum

Dec. 20, 2002

E.U. approval obtained for use of Enbrel in psoriatic arthritis

Dec. 20, 2002

Lantus: E.U. approval for flexible use, positive opinion for pediatric use

Dec. 19, 2002

Approvable letter for Advair Diskus

Dec. 19, 2002

Extended-release Cipro cleared for uncomplicated urinary tract infections

Dec. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...